Singapore: revenue from cardiology devices 2029

The revenue in the 'Cardiology Devices' segment of the medical technology market in Singapore was forecast to continuously increase between 2024 and 2029 by in total 101.4 million U.S. dollars (+64.82 percent). After the ninth consecutive increasing year, the revenue is estimated to reach 257.85 million U.S. dollars and therefore a new peak in 2029.

Find further information concerning the revenue in the 'Medical Devices' segment of the medical technology market in Spain and the revenue in the medical technology market in Spain.

The Statista Market Insights cover a broad range of additional markets.

Revenue from the cardiology devices segment of the medical technology market Singapore from 2016 to 2029 (in million U.S. dollars)

Characteristic	In million U.S. dollars
-	-
-	-
-	-
-	-
-	-
-	-
-	-
-	-
-	-
-	-
-	-
-	-
-	-
-	-

Download

Source

Show detailed source information?

Already a member?

Source

Use Ask Statista Research Service

More information

Supplementary notes

Data provided by Statista Market Insights are estimates.

Definition:
The Cardiology Devices market includes diagnostic, monitoring, and surgical devices that are used to treat heart diseases and heart-related problems.

Additional information:
Market values represent revenues paid to primary vendors at manufacturer price level either directly or through distribution channels (excluding VAT). Reported market revenues include spending by consumers (B2C), enterprises (B2B) as well as governments (B2G). Revenues are allocated to the country where the money is spent.

Company examples: Medtronic, Abbott Laboratories, Boston Scientific, Edwards Lifesciences.
Further information on the key players can be found in the Market Shares boxes.

Citation formats